NCT07911709Completed
Effect of Combined Hormonal Contraceptiveson Free Androgen Index (FAI) in Polycystic Ovary Syndrome:Drospirenone-Ethinyl Estradiol (DRSP-EE) Versus Cyproterone Acetate-Ethinyl Estradiol (CPA-EE)
Source: ClinicalTrials.gov · Last updated 3 Nov 2026
Brief summary (registry, in English)
The goal of this clinical trial is to learn if drug Drospirenone ethinyl estradiol works better than drug Cyproterone acetate ethinyl estradiol to treat PCOS. The main questions it aims to answer are What medical problems do participants have when taking drug Drospirenone ethinyl estradiol and Cyproterone acetate ethinyl estradiol? Researchers will compare drug Drospirenone ethinyl estradiol to drug Cyproterone acetate ethinyl estradiol to see if drug Drospirenone ethinyl estradiol works better than Cyproterone acetate ethinyl estradiol to treat PCOS. Participants will: Take drug Drospirenone ethinyl estradiol or Cyproterone acetate ethinyl estradiol every day for 3 months Visit the clinic after 3 months for checkups and tests Keep a diary of their symptoms
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 60 (actual)
- First submitted
- 28 Oct 2026
- Start date
- 1 Jul 2023
- Primary completion date
- 31 Dec 2024
- Lead sponsor
- Mst.Sumyara Khatun
- NCT number
- NCT07911709
What you commit to
- Study type: Interventional
- Participants enrolled: 60
- From 1 Jul 2023 to the primary completion date, 31 Dec 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- • Cerebrovascular disease
- Coronary artery disease
- Carcinoma of breast or other estrogen dependent neoplasm, undiagnosed abnormal genital bleeding
- Known or suspected pregnancy
- Abnormal liver and renal function
- Uncontrolled DM and HTN, dyslipidemia
- Recent use of androgen and anti-androgens within 3 months and other causes of anovulation/oligovulation.
Who the study is looking for
- clinical hyperandrogenism (hirsutism, acne) or
- polycystic ovarian morphology on ultrasonography \>12 follicles in each ovary measuring 2-9 mm in diameter and/or increased ovarian volumes \> 10cm3(Taylor et al., 2019)
Age in the registry: 20 years to 35 years · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Bangladesh Medical University Coordinator of this site? Confirm its status | Dhaka | Bangladesh | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.